SLC30A7 and neoplasm: Interestingly, the Znt7-knockout increased tumorigenesis in a transgenic mouse model of prostate adenocarcinoma (TRAMP/Znt7−/−), indicating that a reduced expression of this gene might contribute to tumor progression.